Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) FCF Margin (2016 - 2025)

Haemonetics (HAE) has 17 years of FCF Margin data on record, last reported at 25.73% in Q4 2025.

  • For Q4 2025, FCF Margin rose 1562.0% year-over-year to 25.73%; the TTM value through Dec 2025 reached 23.37%, up 1617.0%, while the annual FY2025 figure was 10.47%, 50.0% down from the prior year.
  • FCF Margin reached 25.73% in Q4 2025 per HAE's latest filing, down from 32.48% in the prior quarter.
  • Across five years, FCF Margin topped out at 32.48% in Q3 2025 and bottomed at 9.84% in Q2 2024.
  • Average FCF Margin over 5 years is 10.01%, with a median of 10.75% recorded in 2024.
  • Peak YoY movement for FCF Margin: tumbled -3755bps in 2021, then surged 2114bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 9.44% in 2021, then soared by 65bps to 15.58% in 2022, then plummeted by -129bps to 4.52% in 2023, then skyrocketed by 324bps to 10.1% in 2024, then surged by 155bps to 25.73% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 25.73% in Q4 2025, 32.48% in Q3 2025, and 4.24% in Q2 2025.